Medical Near Infrared Imaging Global Market Report 2025

The medical near infrared imaging market size has grown rapidly in recent years. It will grow from$0.54 billion in 2024 to $0.62 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth during the historic period can be attributed to factors such as the rising burden of cancer, the shift towards minimally invasive procedures, increased healthcare spending and infrastructure development, the integration of NIR imaging in surgical navigation, and the broadening of application areas.

The medical near infrared imaging market size is expected to see rapid growth in the next few years. It will grow to$1.02 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth during the forecast period can be attributed to factors such as an aging population, a continued shift towards minimally invasive procedures, personalized treatment planning and real-time monitoring, an increase in FDA approvals, and a heightened focus on early diagnosis. Key trends in the forecast period include the integration of AI and machine learning, the development of portable and handheld NIR imaging solutions, the advancement of NIR-enabled endoscopes, growing collaborations and partnerships, and the rise of automated and AI-assisted NIR imaging systems.

The increasing prevalence of target diseases is expected to drive the growth of the medical near-infrared (NIR) imaging market in the future. Target diseases refer to specific medical conditions that are the focus of therapeutic interventions, research, or drug development, often based on their prevalence, severity, or availability of effective treatments. The prevalence of these diseases is rising due to greater exposure to environmental and lifestyle risk factors that contribute to the development of chronic and complex conditions requiring specialized treatments. Medical near-infrared imaging is used in diagnosing and monitoring these diseases by providing real-time, non-invasive visualization of tissues and molecular processes, allowing for early diagnosis and accurate tracking of treatment responses. For example, in January 2024, the American Cancer Society, a U.S.-based non-profit organization, reported that the number of new cancer cases in the United States is projected to rise to 2.0 million in 2024, up from 1.96 million in 2023. As a result, the surge in the prevalence of target diseases is fueling the growth of the medical near-infrared imaging market.

Leading companies in the medical near-infrared imaging market are focusing on developing advanced products such as NIR laparoscopic imaging systems to enhance surgical precision and improve real-time tissue visualization. NIR laparoscopic imaging systems utilize near-infrared light to provide enhanced visualization of tissues, blood vessels, and lymph nodes during minimally invasive laparoscopic surgeries. For instance, in November 2024, Irillic Private Ltd., an India-based medical technology company, introduced Irillic L.nm, India's first true 4K NIR laparoscopic imaging system, marking a significant advancement in surgical imaging technology. This innovation brings fluorescence imaging from open surgeries to minimally invasive procedures, providing surgeons with unmatched image clarity and real-time visual enhancements. Featuring advanced imaging modes such as AMVI (advanced microvascular imaging), depth contrast, color fusion, green fusion, and multiview, the system offers greater precision and adaptability during complex procedures.

In July 2022, Getinge AB, a Sweden-based medical technology company, acquired FLUOPTICS SAS for an undisclosed amount. This acquisition strengthens Getinge’s clinical decision support offerings by integrating FLUOPTICS' fluorescence imaging technology, which enhances surgical safety and operational efficiency. FLUOPTICS SAS is a France-based biotechnology company that specializes in providing NIR imaging systems for surgical applications.

Major players in the medical near infrared imaging market are Hamamatsu Photonics K.K., Thermo Fisher Scientific Inc., Medtronic plc, Stryker Corporation, Olympus Corporation, Teledyne Technologies Incorporated, Nipro Corporation, PerkinElmer Inc., Shimadzu Corporation, Bruker Corporation, Karl Storz SE & Co. KG, Leica Microsystems GmbH, Oxford Instruments plc, Mizuho Medical Co. Ltd., LI-COR Inc., BIOPAC Systems Inc., Soterix Medical Inc., Artinis Medical Systems B.V., Gowerlabs Ltd., and Quest Medical Imaging B.V.

North America was the largest region in the medical near infrared imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in medical near infrared imaging report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medical near infrared imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Medical near-infrared imaging (NIR imaging) is a non-invasive technique that utilizes near-infrared light, typically in the wavelength range of 700 to 2500 nanometers, to visualize internal structures and functions within biological tissues. This technology takes advantage of the unique absorption and scattering properties of tissues when exposed to near-infrared light, enabling the detection of abnormalities such as tumors, variations in blood flow, oxygenation levels, and metabolic changes.

The main product categories in medical near-infrared imaging include instruments, accessories, and software. Instruments are specialized devices that employ near-infrared light to non-invasively capture and analyze real-time images of internal body structures for medical diagnostics. Key technologies include continuous wave (CW) near-infrared imaging, pulsed wave near-infrared imaging, and time-domain near-infrared imaging, which are applied in various fields such as oncology, dermatology, cardiovascular imaging, neurology, and other clinical applications. The primary end-users of this technology include hospitals, diagnostic centers, and research institutions.

The medical near infrared imaging market research report is one of a series of new reports that provides medical near infrared imaging market statistics, including the medical near infrared imaging industry global market size, regional shares, competitors with the medical near infrared imaging market share, detailed medical near infrared imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the medical near infrared imaging industry. This medical near infrared imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical near infrared imaging market consists of revenues earned by entities by providing services such as intraoperative imaging, diagnostic imaging, preclinical imaging, contrast agent supply and customization, image data analysis and interpretation, and system integration with technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical near infrared imaging market also includes sales of NIR spectroscopy devices, intraoperative imaging devices, portable NIR imaging devices, indocyanine green (ICG) dyes and reagents, and NIR fluorescence imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.